MDT

99.73

+0.23%↑

146.42

+0.21%↑

VEEV

238.81

+2%↑

HQY

96.63

+3.04%↑

PHR.US

17.41

+1.69%↑

MDT

99.73

+0.23%↑

146.42

+0.21%↑

VEEV

238.81

+2%↑

HQY

96.63

+3.04%↑

PHR.US

17.41

+1.69%↑

MDT

99.73

+0.23%↑

146.42

+0.21%↑

VEEV

238.81

+2%↑

HQY

96.63

+3.04%↑

PHR.US

17.41

+1.69%↑

MDT

99.73

+0.23%↑

146.42

+0.21%↑

VEEV

238.81

+2%↑

HQY

96.63

+3.04%↑

PHR.US

17.41

+1.69%↑

MDT

99.73

+0.23%↑

146.42

+0.21%↑

VEEV

238.81

+2%↑

HQY

96.63

+3.04%↑

PHR.US

17.41

+1.69%↑

Home・Aktien・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

BrancheGesundheitswesen

37.65 3.8

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

36.11

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	11M 51M
Verkäufe	39M 239M
KGV Branchendurchschnitt	11.593 88.032
EPS	1.08
Gewinnspanne	21.242
Angestellte	268
EBITDA	14M 73M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+18.64% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	429M 2.1B
Vorheriger Eröffnungskurs	33.85
Vorheriger Schlusskurs	37.65

Nachrichtenstimmung

By Acuity

50%

164 / 373 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

29.8 / N/A Unterstützung & Widerstand

Harmony Biosciences Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Jan. 2026, 21:14 UTC

Wichtige Markttreiber

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6. Jan. 2026, 19:23 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6. Jan. 2026, 17:41 UTC

Wichtige Markttreiber

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6. Jan. 2026, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Advent International Leads InPost Takeover Offer, Sky News Says

6. Jan. 2026, 15:37 UTC

Wichtige Markttreiber

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6. Jan. 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6. Jan. 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6. Jan. 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Jan. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Jan. 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6. Jan. 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6. Jan. 2026, 20:59 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Could Be Announced Imminently, Sources Say -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6. Jan. 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6. Jan. 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6. Jan. 2026, 19:46 UTC

Akquisitionen, Fusionen, Übernahmen

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6. Jan. 2026, 19:08 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4B Hg Acquisition

6. Jan. 2026, 18:28 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6. Jan. 2026, 17:20 UTC

Market Talk

Ergebnisse

Financial Services Roundup: Market Talk

6. Jan. 2026, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

6. Jan. 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6. Jan. 2026, 15:34 UTC

Market Talk

Ergebnisse

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6. Jan. 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer-Vergleich

Kursveränderung

Harmony Biosciences Holdings Inc Prognose

Kursziel

By TipRanks

18.64% Vorteil

12-Monats-Prognose

Durchschnitt 43.6 USD 18.64%

Hoch 55 USD

Tief 32 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Harmony Biosciences Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

Buy

Halten

Sell

Basierend auf 6 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Harmony Biosciences Holdings Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

29.8 / N/AUnterstützung & Widerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Stimmung

By Acuity

164 / 373 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.